Latest Breaking News On - Pharmaceuticals announces closing - Page 1 : comparemela.com

Cyclacel Pharmaceuticals Announces Closing of $8 0 Million Private Placement Priced At-The-Market Under NASDAQ Rules

02.05.2024 - BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) - Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; Cyclacel or the Company ), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today . Seite 1

United statesCyclacel pharmaceuticals announces closingHc wainwright coCyclacel pharmaceuticals incPharmaceuticals announces closingPrivate placementPriced at the market underSecurities act

Citius Pharmaceuticals Announces Closing of $15 Million Registered Direct Offering

Citius Pharmaceuticals Announces Closing of $15 Million Registered Direct Offering
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesIlanit allenGreg salsburgExchange commissionHc wainwright coPrnewswire citius pharmaceuticals incCitius pharmaceuticals announces closingSecurities exchangeCitius pharmaceuticals incPharmaceuticals announces closingRegistered directCitius pharmaceuticalsBiologics license applicationCitius oncologySecurities act

Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U S Based Seyltx for USD $2M and a 20% Equity Position

Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program by U S Based Seyltx for USD $2M and a 20% Equity Position
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesBritish columbiaUnited kingdomDietricha stephanChristopherj moreauAlgernon ifenprodilMaxim groupCanadian securities exchangeNeither the canadian securities exchangeAlgernon pharmaceuticals announces closing of the acquisitionMerck coAlgernon pharmaceuticalsDrug administrationNo securities exchangeBellus healthAfferent pharmaceuticals

Processa Pharmaceuticals Announces Closing of $7 0 Million Public Offering

Processa Pharmaceuticals Announces Closing of $7 0 Million Public Offering
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesProcessa ngcsPatrick linBret shapiroProcessa pharmaceuticals incProcessa pharmaceuticals announces closingCompany contactExchange commissionHc wainwright coPharmaceuticals announces closingProcessa pharmaceuticalsRegulatory science approachOptimal dosage regimensOptimal dosage regimenOptimus oncology

Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares

Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesEncephalopathies deesWedbush pacgrowBroadridge financial solutionsExchange commissionCantor fitzgerald coLongboard pharmaceuticalsHc wainwright coLongboard pharmaceuticals incPharmaceuticals announces closingPublic offeringCommon stockFull exerciseUnderwriter optionPurchase additional